Jinyu Bio-Technology Co Ltd Class A 600201
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 10.65
- Day Range
- CNY 10.57–10.92
- 52-Week Range
- CNY 6.94–11.03
- Bid/Ask
- CNY 10.83 / CNY 10.84
- Market Cap
- CNY 12.13 Bil
- Volume/Avg
- 24.6 Mil / 15.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 36.97
- Price/Sales
- 7.45
- Dividend Yield (Trailing)
- 0.56%
- Dividend Yield (Forward)
- 0.56%
- Total Yield
- 0.56%
Company Profile
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,654
- Website
- http://www.jinyu.com.cn
Comparables
Valuation
|
Metric
|
600201
|
001222
|
002567
|
|---|---|---|---|
Price/Earnings (Normalized) | 36.97 | 17.57 | — |
Price/Book Value | 2.17 | 2.14 | 1.89 |
Price/Sales | 7.45 | 2.52 | 0.39 |
Price/Cash Flow | 23.76 | 31.78 | 14.10 |
Price/Earnings
600201
001222
002567
Financial Strength
|
Metric
|
600201
|
001222
|
002567
|
|---|---|---|---|
Quick Ratio | — | 5.42 | 0.53 |
Current Ratio | — | 7.19 | 1.08 |
Interest Coverage | — | 230.38 | −4.05 |
Quick Ratio
600201
001222
002567
Profitability
|
Metric
|
600201
|
001222
|
002567
|
|---|---|---|---|
Return on Assets (Normalized) | 3.70% | 11.57% | −7.50% |
Return on Equity (Normalized) | 4.70% | 14.47% | −22.70% |
Return on Invested Capital (Normalized) | 3.59% | 11.89% | −8.11% |
Return on Assets
600201
001222
002567
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Yzcqjwhcg | Bjj | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Thlnbpyvv | Hmdhjk | $115.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Hxxjfkdyp | Tkkqlfz | $108.2 Bil | |
MRNA
| Moderna Inc | Gclmlpszz | Nbtg | $54.0 Bil | |
BNTX
| BioNTech SE ADR | Qnqcymb | Vzmj | $21.8 Bil | |
ARGX
| argenx SE ADR | Fkjbsycw | Cqky | $21.6 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Fntqrnzr | Zddklt | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Lmmfdrlvc | Rdpgspb | $14.6 Bil | |
INCY
| Incyte Corp | Pqhtknxn | Mgnqv | $12.9 Bil | |
RPRX
| Royalty Pharma PLC Class A | Svbgwvsbg | Rqvjxf | $12.3 Bil |